Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Tarveda Therapeutics was a clinical-stage biopharmaceutical company dedicated to the discovery and development of Pentarin® miniature drug conjugates. These novel therapeutics were designed to deeply penetrate solid tumors and release their potent anti-cancer payloads directly at the site of disease, aiming to improve efficacy and reduce systemic toxicity. Tarveda's platform sought to overcome the limitations of traditional antibody-drug conjugates by creating smaller, more targeted molecules. The company advanced multiple candidates into clinical development for various oncology indications. In November 2020, Tarveda Therapeutics was acquired by Shattuck Labs.
The headquarters served as the primary center for Tarveda's operations, including pioneering research and development of its Pentarin® platform, managing clinical trials, and housing all corporate and administrative functions prior to its acquisition.
The facility was likely equipped with state-of-the-art laboratory facilities necessary for advanced biopharmaceutical research, drug discovery, and preclinical development, alongside modern office spaces designed to foster collaboration among scientific and corporate teams.
As a clinical-stage biotechnology company, Tarveda Therapeutics likely fostered a dynamic, fast-paced, and innovative work culture. This typically involved a strong emphasis on scientific rigor, close collaboration between research, clinical, and corporate departments, and a shared, mission-driven focus on developing impactful cancer therapies for patients with unmet medical needs.
The Watertown headquarters was crucial as the birthplace of Tarveda's innovative Pentarin® platform and the nerve center for its drug development programs. Its location within the Boston biotech hub provided access to talent, resources, and a collaborative scientific community.
Prior to its acquisition, Tarveda Therapeutics's operational footprint was primarily concentrated in the United States, with its research, drug development, and clinical trial management largely orchestrated from its US headquarters in Massachusetts. While its therapeutic candidates were developed with the potential for global impact on cancer patients, its physical operational presence was mainly US-based. Global activities would have included collaborations or clinical trial sites in other regions as part of its development programs.
134 Coolidge Avenue
Watertown
MA
USA
Address: Tarveda Therapeutics primarily operated from its headquarters in Watertown, MA.
The company's focus was consolidated at its main research and corporate headquarters to streamline development efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Tarveda Therapeutics' leadership includes:
Tarveda Therapeutics has been backed by several prominent investors over the years, including:
Tarveda Therapeutics was acquired by Shattuck Labs in November 2020. Consequently, its executive team transitioned, and the company ceased independent operations. There have been no new hires or exits attributable to Tarveda Therapeutics as an independent entity in the last 12 months. The most significant recent executive event was the dissolution of its leadership team post-acquisition.
Discover the tools Tarveda Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition and cessation of independent operations, Tarveda Therapeutics likely used standard corporate email formats. Common patterns in the biotech industry include [first_initial][last]@[companydomain].com or [first].[last]@[companydomain].com. The domain tarveda.com is no longer active for email.
flast@tarveda.com (example: jdoe@tarveda.com)
Format
jdoe@tarveda.com
Example
0%
Success rate
PR Newswire (Shattuck Labs) • November 18, 2020
Shattuck Labs, Inc., a clinical-stage biotechnology company, announced its acquisition of Tarveda Therapeutics, Inc. This strategic move was aimed at enhancing Shattuck's pipeline with Tarveda's innovative Pentarin® platform and its lead clinical candidate, PEN-866, designed for treating solid tumors....more
Business Wire (Tarveda Therapeutics) • February 12, 2019
Tarveda Therapeutics announced the successful completion of a $30 million Series D financing round. The proceeds were designated for advancing its lead Pentarin® clinical candidate, PEN-866, through clinical trials and for the continued development of its proprietary Pentarin platform for creating targeted miniature drug conjugates....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Tarveda Therapeutics, are just a search away.